Michael I. Levi <br/><br/>
Basic Notes in Psychopharmacology 

 - revised  
 - Boston   Radcliffe Publishing  c2007 
 - 	152 pages  
 - Radcliffe Series  .
<br/><br/>Contents:<br/><br/>Antipsychotic drugs<br/><br/>Antidepressant drugs<br/><br/>Antimanic drugs<br/><br/>AppliedClinical Psychopharmacology<br/><br/>Nonresistant depression<br/><br/>Depressive disorder in a patient withcardiovascular disease<br/><br/>Nonresistant bipolar a ective disorder mania<br/><br/>Antidepressantinduced switching to mania in bipolar<br/><br/>Schizoa ective disorder schizomania<br/><br/>Acute organic disorder<br/><br/>Alzheimers disease mild to moderate<br/><br/>Anorexia nervosa<br/><br/>Acute alcohol withdrawalalcohol dependence<br/><br/>Acute opiate withdrawalchronic opiate dependence<br/><br/>Acute benzodiazepine withdrawalchronic benzodiazepine dependence<br/><br/>Selfinjurious behaviour SIBlearning disabilitytemporal lobe epilepsy<br/><br/>Resistant schizophrenia<br/><br/>Schizophrenia with negative symptoms<br/><br/>Schizophreniform psychosis in a patient with epilepsy<br/><br/>Schizophrenia in pregnancy<br/><br/>The acutely disturbed patient rapid tranquillisation<br/><br/>Index<br/> 
<br/><br/> Now in its fourth edition, Basic Notes in Psychopharmacology is a concise summary, in the form of notes, which gives the reader a quick and easy-to-use overview of the subject. This greatly expanded volume now covers all the major classes of drugs, and for each individual drug the principle mode of action, indications and adverse effects are provided. In addition, it now includes 35 peer-reviewed clinical vignettes, focussing on psychopharmacological treatments which play a major part in management. As a short and practical guide, it will be invaluable for junior hospital psychiatrists, general practitioners and medical students. Others, including psychiatric nurses, psychiatric social workers, psychiatric occupational therapists and clinical psychologists, will also find it extremely useful. 
<br/><br/><label>ISBN: </label>1846191874 9781846191879  
 = 5HT2A-receptors admission Adverse e ects affective disorder mania alcohol anti anticholinergic anticholinergic side-e ects antidepressant drug antimanic drug antipsychotic depot injection anxiolytic atypical antipsychotic behaviour benzodiazepine bipolar a ective bipolar affective disorder carbamazepine chlorpromazine citalopram class of antidepressant clinical guidelines clozapine consider switching currently licensed daily in divided decanoate dementia depressive disorders diagnosis divided doses dosage dose range ective disorder epilepsy episode EPSE exhibited fails to respond haloperidol High a nity increased Indications 1 Treatment lithium carbonate lorazepam Low a nity MAOIs maximum dose medication mg bd mg daily mg mane mirtazapine Mode of action NaSSA nity for serotonin olanzapine panic disorder paroxetine patient fails psychotic receptors relapse resistant depression reuptake inhibitors SSRIs risperidone schizophrenia second SSRI seizures selective serotonin reuptake serotonin reuptake inhibitors sertraline side-effects signi®cant SNRI sodium valproate speci®c SSRI starting dose TCAs Treatment of depression valproate semisodium venlafaxine venlafaxine XL weight gain 
<br/><br/><label>Subjects--Personal Names: </label>--Psychotropic drugs--Handbooks, manuals, etc. --Psychopharmacology--Handbooks, manuals, etc.--	Medical › Psychiatry › Psychopharmacology -- Medical / Pharmacology-- Medical / Psychiatry / Psychopharmacology  	    
<br/><br/><label>Dewey Class. No.: </label>615/.788 LEV